BioGaia AB (publ) (BGLAF)
- Previous Close
0.00 - Open
12.31 - Bid 9.28 x 36200
- Ask 9.83 x 40000
- Day's Range
12.31 - 12.31 - 52 Week Range
9.00 - 12.31 - Volume
257 - Avg. Volume
5 - Market Cap (intraday)
1.023B - Beta (5Y Monthly) 0.55
- PE Ratio (TTM)
32.81 - EPS (TTM)
0.32 - Earnings Date Oct 22, 2024
- Forward Dividend & Yield 0.18 (1.67%)
- Ex-Dividend Date May 8, 2024
- 1y Target Est
--
BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.
www.biogaia.com222
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: BGLAF
View More
Performance Overview: BGLAF
Trailing total returns as of 10/28/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BGLAF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BGLAF
View MoreValuation Measures
Market Cap
969.61M
Enterprise Value
864.15M
Trailing P/E
33.32
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.30
Price/Book (mrq)
6.95
Enterprise Value/Revenue
6.74
Enterprise Value/EBITDA
17.85
Financial Highlights
Profitability and Income Statement
Profit Margin
24.84%
Return on Assets (ttm)
13.62%
Return on Equity (ttm)
18.69%
Revenue (ttm)
1.36B
Net Income Avi to Common (ttm)
336.82M
Diluted EPS (ttm)
0.32
Balance Sheet and Cash Flow
Total Cash (mrq)
1.11B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
248.77M
Company Insights: BGLAF
BGLAF does not have Company Insights